Just weeks after announcing it would "step up" its acquisitions this year, Medtronic said it will shell out up to $58...
Medtronic will pay up to $585 million to acquire privately held CathWorks, an Israeli developer of coronary artery disease diagnostic and treatment devices, signaling an acceleration in the company's acquisition strategy.
Why it mattersMedtronic's $585 million CathWorks acquisition for coronary artery disease should prompt VCs to increase exit expectations.